Overview

Bupropion for Hospitalized Smokers With Acute Cardiovascular Disease

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to test the efficacy and safety of bupropion SR for smokers hospitalized with acute cardiovascular disease.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
GlaxoSmithKline
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Bupropion